Cite
HARVARD Citation
Carbognin, L. et al. (2015). Balancing activity and tolerability of neoadjuvant paclitaxel- and docetaxel-based chemotherapy for HER2-positive early stage breast cancer: Sensitivity analysis of randomized trials. Cancer treatment reviews. 41 (3), pp. 262-270. [Online].